\chapter{Experimental and Emerging Therapies}
\label{ch:emerging-therapies}

\section{Immunological Interventions}
\label{sec:immunological-interventions}

\subsection{Cytokine Modulation}
% Anti-TNF therapies
% IL-6 inhibition
% JAK inhibitors
% Clinical trials

\subsection{Cellular Therapies}
% Mesenchymal stem cells
% NK cell therapy
% Dendritic cell vaccines

\section{Metabolic Interventions}
\label{sec:metabolic-interventions}

\subsection{Metabolic Modulators}
% Dichloroacetate (DCA)
% Pyruvate dehydrogenase activation
% Other experimental compounds

\subsection{Mitochondrial Transplantation}
% Theoretical basis
% Early research

\section{Neurological Interventions}
\label{sec:neurological-interventions}

\subsection{Neurostimulation}
% Transcranial magnetic stimulation (TMS)
% Vagal nerve stimulation
% tDCS (transcranial direct current stimulation)

\subsection{Cerebrospinal Fluid Interventions}
% Spinal fusion for craniocervical instability
% CSF pressure management

\section{Microbiome Interventions}
\label{sec:microbiome-interventions}

% Fecal microbiota transplantation (FMT)
% Targeted probiotics
% Phage therapy
% Precision prebiotics

\section{Repurposed Medications}
\label{sec:repurposed-medications}

\subsection{Metformin}
% Metabolic effects
% Potential benefits
% Ongoing research

\subsection{Abilify (Aripiprazole)}
% Dopamine modulation
% Stanford trial
% Considerations

\subsection{BC007}
% Autoantibody removal
% Clinical trials
% Mechanism

\subsection{Other Candidates}
% Suramin
% Rapamycin
% Thymosin alpha-1

\section{Technologies and Devices}
\label{sec:technologies}

\subsection{Apheresis}
% Plasma exchange
% Immunoadsorption
% Evidence

\subsection{Hyperbaric Oxygen Therapy}
% Rationale
% Evidence
% Practical considerations

\subsection{Photobiomodulation}
% Red and near-infrared light therapy
% Mitochondrial effects
% Evidence

\section{Peptide Therapies}
\label{sec:peptides}

% BPC-157
% Thymosin beta-4
% Other peptides under investigation

\section{Evaluating Emerging Therapies}
\label{sec:evaluating-therapies}

% Clinical trial phases
% Evidence levels
% Risk assessment
% Access pathways
